Qingdao Haier Biomedical Co Ltd Relative Valuation - Qingdao Haier Biomedical Co Ltd

Watchlist Manager

Watchlist

Price: 32.41 CNY -2.53% Market Closed

Market Cap: ¥10.3B

	Qingdao Haier Biomedical Co Ltd SSE:688139	CN

Multiples-Based Value

The Multiples-Based Value for Qingdao Haier Biomedical Co Ltd (688139) under the Base Case is 26.29 CNY. Compared with the current market price of 32.41 CNY, the stock appears Overvalued by 19%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

Multiples-Based Value

Overvaluation 19%

Multiples-Based Value

Price ¥32.41

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

		Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN	Qingdao Haier Biomedical Co Ltd SSE:688139	10.3B CNY	4.6	40.3	45	45
US	Abbott Laboratories NYSE:ABT	176.4B USD	4	27	15.5	21.3
US	Intuitive Surgical Inc NASDAQ:ISRG	166.3B USD	16.5	58.2	44.1	54.2
US	Stryker Corp NYSE:SYK	130.5B USD	5.2	40.2	20.5	24.8
IE	Medtronic PLC NYSE:MDT	111.8B USD	3.2	24.2	13.4	19.5
US	Boston Scientific Corp NYSE:BSX	95.8B USD	4.8	33.1	19.6	26.3
DE	Siemens Healthineers AG XETRA:SHL	43.2B EUR	1.9	20.6	11.5	16.2
US	IDEXX Laboratories Inc NASDAQ:IDXX	46.3B USD	10.8	43.7	30.9	34.2
US	Edwards Lifesciences Corp NYSE:EW	45.4B USD	7.5	42.3	23	25.1
US	Becton Dickinson and Co NYSE:BDX	44.3B USD	2	25.2	10	16.9
US	GE Healthcare Technologies Inc NASDAQ:GEHC	33.5B USD	1.6	16.1	11.5	14

			Revenue Growth	P/S to Growth
CN	Qingdao Haier Biomedical Co Ltd SSE:688139	Average P/S: 5.6 4.6	12%	0.4
US	Abbott Laboratories NYSE:ABT	4	8%	0.5
US	Intuitive Surgical Inc NASDAQ:ISRG	16.5	15%	1.1
US	Stryker Corp NYSE:SYK	5.2	9%	0.6
IE	Medtronic PLC NYSE:MDT	3.2	7%	0.5
US	Boston Scientific Corp NYSE:BSX	4.8	11%	0.4
DE	Siemens Healthineers AG XETRA:SHL	1.9	5%	0.4
US	IDEXX Laboratories Inc NASDAQ:IDXX	10.8	10%	1.1
US	Edwards Lifesciences Corp NYSE:EW	7.5	11%	0.7
US	Becton Dickinson and Co NYSE:BDX	2	-2%	N/A
US	GE Healthcare Technologies Inc NASDAQ:GEHC	1.6	5%	0.3

			Earnings Growth	PEG
CN	Qingdao Haier Biomedical Co Ltd SSE:688139	Average P/E: 33.7 40.3	6%	6.7
US	Abbott Laboratories NYSE:ABT	27	23%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	58.2	19%	3.1
US	Stryker Corp NYSE:SYK	40.2	30%	1.3
IE	Medtronic PLC NYSE:MDT	24.2	22%	1.1
US	Boston Scientific Corp NYSE:BSX	33.1	32%	1
DE	Siemens Healthineers AG XETRA:SHL	20.6	16%	1.3
US	IDEXX Laboratories Inc NASDAQ:IDXX	43.7	13%	3.4
US	Edwards Lifesciences Corp NYSE:EW	42.3	27%	1.6
US	Becton Dickinson and Co NYSE:BDX	25.2	35%	0.7
US	GE Healthcare Technologies Inc NASDAQ:GEHC	16.1	11%	1.5

			EBITDA Growth	EV/EBITDA to Growth
CN	Qingdao Haier Biomedical Co Ltd SSE:688139	Average EV/EBITDA: 22.3 45	17%	2.6
US	Abbott Laboratories NYSE:ABT	15.5	11%	1.4
US	Intuitive Surgical Inc NASDAQ:ISRG	44.1	23%	1.9
US	Stryker Corp NYSE:SYK	20.5	12%	1.7
IE	Medtronic PLC NYSE:MDT	13.4	8%	1.7
US	Boston Scientific Corp NYSE:BSX	19.6	18%	1.1
DE	Siemens Healthineers AG XETRA:SHL	11.5	10%	1.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	30.9	11%	2.8
US	Edwards Lifesciences Corp NYSE:EW	23	14%	1.6
US	Becton Dickinson and Co NYSE:BDX	10	1%	10
US	GE Healthcare Technologies Inc NASDAQ:GEHC	11.5	12%	1

			EBIT Growth	EV/EBIT to Growth
CN	Qingdao Haier Biomedical Co Ltd SSE:688139	Average EV/EBIT: 27 45	25%	1.8
US	Abbott Laboratories NYSE:ABT	21.3	18%	1.2
US	Intuitive Surgical Inc NASDAQ:ISRG	54.2	25%	2.2
US	Stryker Corp NYSE:SYK	24.8	16%	1.6
IE	Medtronic PLC NYSE:MDT	19.5	17%	1.1
US	Boston Scientific Corp NYSE:BSX	26.3	25%	1.1
DE	Siemens Healthineers AG XETRA:SHL	16.2	15%	1.1
US	IDEXX Laboratories Inc NASDAQ:IDXX	34.2	12%	2.8
US	Edwards Lifesciences Corp NYSE:EW	25.1	15%	1.7
US	Becton Dickinson and Co NYSE:BDX	16.9	15%	1.1
US	GE Healthcare Technologies Inc NASDAQ:GEHC	14	14%	1

Qingdao Haier Biomedical Co Ltd
SSE:688139

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Qingdao Haier Biomedical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Qingdao Haier Biomedical Co Ltd SSE:688139

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples Qingdao Haier Biomedical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Qingdao Haier Biomedical Co Ltd
SSE:688139

Competitors Multiples
Qingdao Haier Biomedical Co Ltd Competitors